News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
703,562 Results
Type
Article (40853)
Company Profile (275)
Press Release (662434)
Section
Business (206303)
Career Advice (2011)
Deals (35735)
Drug Delivery (96)
Drug Development (82336)
Employer Resources (172)
FDA (16308)
Job Trends (14996)
News (348928)
Policy (32756)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2586)
Accelerated approval (2)
Adcomms (23)
Allergies (80)
Alliances (50162)
ALS (82)
Alzheimer's disease (1351)
Antibody-drug conjugate (ADC) (124)
Approvals (16307)
Artificial intelligence (236)
Autoimmune disease (14)
Automation (14)
Bankruptcy (361)
Best Places to Work (11773)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (199)
Bladder cancer (61)
Brain cancer (26)
Breast cancer (252)
Cancer (2037)
Cardiovascular disease (147)
Career advice (1677)
Career pathing (29)
CAR-T (146)
Cell therapy (404)
Cervical cancer (18)
Clinical research (66703)
Collaboration (775)
Compensation (451)
Complete response letters (19)
COVID-19 (2593)
CRISPR (35)
C-suite (210)
Cystic fibrosis (98)
Data (1906)
Decentralized trials (2)
Denatured (16)
Depression (37)
Diabetes (241)
Diagnostics (6403)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (113)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (84)
Earnings (86670)
Editorial (33)
Employer branding (21)
Employer resources (146)
Events (113451)
Executive appointments (632)
FDA (17406)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (688)
Gene editing (96)
Generative AI (22)
Gene therapy (272)
GLP-1 (686)
Government (4406)
Grass and pollen (4)
Guidances (48)
Healthcare (19042)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (107)
Indications (26)
Infectious disease (2722)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (84)
Interviews (311)
IPO (16614)
IRA (41)
Job creations (3655)
Job search strategy (1426)
Kidney cancer (10)
Labor market (34)
Layoffs (465)
Leadership (15)
Legal (7928)
Liver cancer (73)
Lung cancer (302)
Lymphoma (130)
Machine learning (2)
Management (58)
Manufacturing (266)
MASH (59)
Medical device (13363)
Medtech (13368)
Mergers & acquisitions (19586)
Metabolic disorders (622)
Multiple sclerosis (68)
NASH (16)
Neurodegenerative disease (76)
Neuropsychiatric disorders (24)
Neuroscience (1814)
NextGen: Class of 2025 (6577)
Non-profit (4511)
Northern California (2395)
Now hiring (37)
Obesity (339)
Opinion (207)
Ovarian cancer (73)
Pain (75)
Pancreatic cancer (77)
Parkinson's disease (130)
Partnered (18)
Patents (201)
Patient recruitment (95)
Peanut (46)
People (57745)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20837)
Phase II (29358)
Phase III (21902)
Pipeline (969)
Podcasts (51)
Policy (108)
Postmarket research (2594)
Preclinical (8779)
Press Release (64)
Prostate cancer (94)
Psychedelics (31)
Radiopharmaceuticals (255)
Rare diseases (352)
Real estate (5960)
Recruiting (65)
Regulatory (22333)
Reports (46)
Research institute (2366)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (63)
Series A (123)
Series B (78)
Service/supplier (11)
Sickle cell disease (50)
Southern California (2068)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3636)
State (2)
Stomach cancer (14)
Supply chain (59)
The Weekly (32)
United States (21015)
Vaccines (662)
Venture capitalists (37)
Webinars (12)
Weight loss (227)
Women's health (33)
Worklife (15)
Date
Today (115)
Last 7 days (570)
Last 30 days (2694)
Last 365 days (33914)
2025 (7714)
2024 (35676)
2023 (40498)
2022 (51695)
2021 (56233)
2020 (54539)
2019 (47056)
2018 (35455)
2017 (32656)
2016 (32027)
2015 (38064)
2014 (31749)
2013 (26719)
2012 (28926)
2011 (29660)
2010 (27609)
Location
Africa (726)
Alabama (54)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (38436)
Australia (6288)
California (5473)
Canada (1857)
China (475)
Colorado (244)
Connecticut (257)
Delaware (123)
Europe (83436)
Florida (809)
Georgia (191)
Idaho (58)
Illinois (497)
India (23)
Indiana (289)
Iowa (9)
Japan (141)
Kansas (101)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (833)
Massachusetts (4170)
Michigan (208)
Minnesota (370)
Mississippi (2)
Missouri (75)
Montana (29)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1552)
New Mexico (28)
New York (1566)
North Carolina (916)
North Dakota (7)
Northern California (2395)
Ohio (190)
Oklahoma (14)
Oregon (33)
Pennsylvania (1245)
Puerto Rico (9)
Rhode Island (26)
South America (1106)
South Carolina (18)
South Dakota (1)
Southern California (2068)
Tennessee (93)
Texas (813)
Utah (163)
Virginia (127)
Washington D.C. (58)
Washington State (507)
West Virginia (3)
Wisconsin (49)
703,562 Results for "revitope oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Revitope Enters into a License Agreement for Next-generation T Cell Engagement Technology
October 29, 2024
·
3 min read
Press Releases
NCCN Announces New Gastrointestinal Cancer Research Grants in Collaboration with Taiho Oncology, Inc.
February 26, 2025
·
4 min read
Collaboration
Incyte Backs Out of Immuno-Oncology Pact With Agenus
The partnership dates back to 2015, when Incyte paid $60 million upfront for access to four checkpoint programs, including TIM-3, LAG-3, OX40 and GITR.
February 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update
February 17, 2025
·
11 min read
Cancer
The Search for the Next Keytruda: Immuno-Oncology’s Next Play
More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a crossroads, with experts highlighting novel targets, combinations and pre-emptive immunization as the next wave for IO.
March 3, 2025
·
7 min read
·
Heather McKenzie
Press Releases
Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.
November 25, 2024
·
7 min read
Press Releases
Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
December 29, 2024
·
11 min read
Press Releases
Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting
January 13, 2025
·
3 min read
Press Releases
TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors
March 12, 2025
·
8 min read
Deals
BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal
In a move straight out of 2021, BridgeBio Oncology is taking the SPAC route to the public markets in a deal with Helix Acquisition Corp. II worth $450 million in proceeds.
February 28, 2025
·
2 min read
·
Annalee Armstrong
1 of 70,357
Next
